Scotland’s Industrial Biotechnology Sector Exceeds Growth Expectations

The motion

That the Parliament welcomes reports that Scotland’s industrial biotechnology companies are exceeding growth expectations; recognises that, according to the Industrial Biotechnology Innovation Centre, the sector turnover is now worth £747 million; notes that this is an increase from £189 million on 2012, almost 300%, while the number of biotech companies has grown from 24 in 2012 to 130, creating and sustaining well-paid and highly-skilled employment; believes that this is far greater than the ambitions set out in the 2013 National Plan for Industrial Biotechnology to reach a £400 million turnover by 2020; understands that industrial biotechnology is a set of technologies that create materials and products that have traditionally been made from fossil fuels, with sustainable ingredients in order to maximise re-use and reduce waste in the process; believes that the industry will play an important part in Scotland’s transition to a bioeconomy and in achieving its net-zero targets; congratulates all of the businesses and employees involved in industrial biotechnology on this milestone achievement, and wishes them all the best in their current and future endeavours.

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

SNP 14

Party shown is each supporter’s party when the motion was published.

No contribution in the Official Report cites S5M-24142 by reference.